
Syed Taha Iqbal
Examiner (ID: 5838, Phone: (571)270-5857 , Office: P/1736 )
| Most Active Art Unit | 1736 |
| Art Unit(s) | 1793, 1736 |
| Total Applications | 941 |
| Issued Applications | 713 |
| Pending Applications | 67 |
| Abandoned Applications | 178 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13736549
[patent_doc_number] => 20180372742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => Babesia Biomarkers for Diagnostic and Screening In Vitro Diagnostic Test
[patent_app_type] => utility
[patent_app_number] => 16/060381
[patent_app_country] => US
[patent_app_date] => 2016-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6776
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060381
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/060381 | Babesia Biomarkers for Diagnostic and Screening In Vitro Diagnostic Test | Dec 8, 2016 | Abandoned |
Array
(
[id] => 12808708
[patent_doc_number] => 20180161406
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-14
[patent_title] => Botulinum Neurotoxin Compositions
[patent_app_type] => utility
[patent_app_number] => 15/372560
[patent_app_country] => US
[patent_app_date] => 2016-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5798
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15372560
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/372560 | Botulinum neurotoxin compositions | Dec 7, 2016 | Issued |
Array
(
[id] => 16970748
[patent_doc_number] => 11066711
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-07-20
[patent_title] => Biomarkers for predicting
[patent_app_type] => utility
[patent_app_number] => 16/060152
[patent_app_country] => US
[patent_app_date] => 2016-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 20
[patent_no_of_words] => 7725
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 91
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060152
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/060152 | Biomarkers for predicting | Dec 7, 2016 | Issued |
Array
(
[id] => 11943269
[patent_doc_number] => 20170247420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-31
[patent_title] => 'PREVENTION, TREATMENT AND DIAGNOSIS OF P.GINGIVALIS INFECTION'
[patent_app_type] => utility
[patent_app_number] => 15/370144
[patent_app_country] => US
[patent_app_date] => 2016-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16890
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15370144
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/370144 | PREVENTION, TREATMENT AND DIAGNOSIS OF P.GINGIVALIS INFECTION | Dec 5, 2016 | Abandoned |
Array
(
[id] => 16142021
[patent_doc_number] => 10704075
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Method for determining the reaction of a microorganism to its exposure to a chemical compound
[patent_app_type] => utility
[patent_app_number] => 15/779295
[patent_app_country] => US
[patent_app_date] => 2016-11-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 13
[patent_no_of_words] => 9660
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15779295
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/779295 | Method for determining the reaction of a microorganism to its exposure to a chemical compound | Nov 24, 2016 | Issued |
Array
(
[id] => 13519581
[patent_doc_number] => 20180311333
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect
[patent_app_type] => utility
[patent_app_number] => 15/771635
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22290
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -52
[patent_words_short_claim] => 141
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15771635
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/771635 | Injectable Botulinum Toxin Formulations And Methods Of Use Thereof Having Long Duration Of Therapeutic Or Cosmetic Effect | Oct 27, 2016 | Abandoned |
Array
(
[id] => 13024621
[patent_doc_number] => 10034923
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-31
[patent_title] => Methods for treatment of incontinence associated with sexual activity
[patent_app_type] => utility
[patent_app_number] => 15/337096
[patent_app_country] => US
[patent_app_date] => 2016-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8078
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15337096
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/337096 | Methods for treatment of incontinence associated with sexual activity | Oct 27, 2016 | Issued |
Array
(
[id] => 13507765
[patent_doc_number] => 20180305425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-25
[patent_title] => Factor H-Fc Immunotheraphy
[patent_app_type] => utility
[patent_app_number] => 15/770965
[patent_app_country] => US
[patent_app_date] => 2016-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15887
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15770965
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/770965 | Factor H-Fc immunotheraphy | Oct 26, 2016 | Issued |
Array
(
[id] => 11441963
[patent_doc_number] => 20170042983
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-16
[patent_title] => 'LONG LASTING EFFECT OF NEW BOTULINUM TOXIN FORMULATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/336119
[patent_app_country] => US
[patent_app_date] => 2016-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 15583
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15336119
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/336119 | Long lasting effect of new botulinum toxin formulations | Oct 26, 2016 | Issued |
Array
(
[id] => 11434851
[patent_doc_number] => 20170035873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-09
[patent_title] => 'METHODS AND MATERIALS FOR PRODUCING IMMUNE RESPONSES AGAINST POLYPEPTIDES INVOLVED IN ANTIBIOTIC RESISTANCE'
[patent_app_type] => utility
[patent_app_number] => 15/332831
[patent_app_country] => US
[patent_app_date] => 2016-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3773
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15332831
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/332831 | Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance | Oct 23, 2016 | Issued |
Array
(
[id] => 11421650
[patent_doc_number] => 20170029795
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'Methods and Systems for Purifying Non-Complexed Botulinum Neurotoxin'
[patent_app_type] => utility
[patent_app_number] => 15/295134
[patent_app_country] => US
[patent_app_date] => 2016-10-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 10948
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15295134
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/295134 | Methods and Systems for Purifying Non-Complexed Botulinum Neurotoxin | Oct 16, 2016 | Abandoned |
Array
(
[id] => 11422764
[patent_doc_number] => 20170030908
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-02-02
[patent_title] => 'KIT FOR LABELLING BACTERIA'
[patent_app_type] => utility
[patent_app_number] => 15/293425
[patent_app_country] => US
[patent_app_date] => 2016-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 13934
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15293425
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/293425 | Kit for labelling bacteria | Oct 13, 2016 | Issued |
Array
(
[id] => 11713452
[patent_doc_number] => 20170181952
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-29
[patent_title] => 'BOTULINUM NANOEMULSIONS'
[patent_app_type] => utility
[patent_app_number] => 15/288311
[patent_app_country] => US
[patent_app_date] => 2016-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 22196
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15288311
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/288311 | Botulinum nanoemulsions | Oct 6, 2016 | Issued |
Array
(
[id] => 17192123
[patent_doc_number] => 11160855
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-02
[patent_title] => Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
[patent_app_type] => utility
[patent_app_number] => 15/286696
[patent_app_country] => US
[patent_app_date] => 2016-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 65507
[patent_no_of_claims] => 48
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15286696
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/286696 | Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof | Oct 5, 2016 | Issued |
Array
(
[id] => 14360645
[patent_doc_number] => 10301610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-28
[patent_title] => Filamentous fungal host cell for producing multiple recombinant polypeptides
[patent_app_type] => utility
[patent_app_number] => 15/280706
[patent_app_country] => US
[patent_app_date] => 2016-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 52888
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 209
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15280706
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/280706 | Filamentous fungal host cell for producing multiple recombinant polypeptides | Sep 28, 2016 | Issued |
Array
(
[id] => 12015828
[patent_doc_number] => 09808515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-07
[patent_title] => 'Treatment of social anxiety disorder using botulinum toxin'
[patent_app_type] => utility
[patent_app_number] => 15/277909
[patent_app_country] => US
[patent_app_date] => 2016-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 10553
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15277909
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/277909 | Treatment of social anxiety disorder using botulinum toxin | Sep 26, 2016 | Issued |
Array
(
[id] => 11491529
[patent_doc_number] => 20170065714
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-09
[patent_title] => 'IMMUNOGENIC COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/265597
[patent_app_country] => US
[patent_app_date] => 2016-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 20436
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15265597
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/265597 | Immunogenic composition | Sep 13, 2016 | Issued |
Array
(
[id] => 17322569
[patent_doc_number] => 11213555
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-04
[patent_title] => Intravenous injection for enhancing immune function
[patent_app_type] => utility
[patent_app_number] => 16/331590
[patent_app_country] => US
[patent_app_date] => 2016-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 3
[patent_no_of_words] => 8878
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16331590
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/331590 | Intravenous injection for enhancing immune function | Sep 7, 2016 | Issued |
Array
(
[id] => 13675135
[patent_doc_number] => 20160376301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-29
[patent_title] => PURIFICATION OF STAPHYLOCOCCUS AUREUS TYPE 5 AND TYPE 8 CAPSULAR SACCHARIDES
[patent_app_type] => utility
[patent_app_number] => 15/258881
[patent_app_country] => US
[patent_app_date] => 2016-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19624
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15258881
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/258881 | PURIFICATION OF STAPHYLOCOCCUS AUREUS TYPE 5 AND TYPE 8 CAPSULAR SACCHARIDES | Sep 6, 2016 | Abandoned |
Array
(
[id] => 11527261
[patent_doc_number] => 20170087238
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-30
[patent_title] => 'Immunizing compositions and methods of use'
[patent_app_type] => utility
[patent_app_number] => 15/258792
[patent_app_country] => US
[patent_app_date] => 2016-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 21814
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15258792
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/258792 | Immunizing compositions and methods of use | Sep 6, 2016 | Abandoned |